申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2017134098A1
公开(公告)日:2017-08-10
The present invention relates to novel, selective radiolabelled tau ligands which are useful for imaging and quantifying tau aggregates, using positron-emission tomography (PET). The invention is also directed to compositions comprising such compounds, to processes for preparing such compounds and compositions, to the use of such compounds and compositions for imaging a tissue or a subject, in vitro or in vivo, and to precursors of said compounds.
本发明涉及新颖的、选择性放射性标记的tau配体,用于使用正电子发射断层扫描(PET)成像和定量tau聚集物。该发明还涉及包含这种化合物的组合物,制备这种化合物和组合物的方法,使用这种化合物和组合物在体内或体外成像组织或受试者,以及这种化合物的前体。